CVI Holdings LLC bought a new position in shares of Surrozen, Inc. (NASDAQ:SRZN – Free Report) in the second quarter, Holdings Channel reports. The firm bought 64,905 shares of the company’s stock, valued at approximately $711,000. Surrozen accounts for 0.6% of CVI Holdings LLC’s portfolio, making the stock its 23rd largest position.
Separately, Armistice Capital LLC bought a new stake in Surrozen during the second quarter worth approximately $2,080,000. 66.57% of the stock is owned by hedge funds and other institutional investors.
Surrozen Stock Down 0.8 %
Shares of Surrozen stock opened at $10.25 on Friday. The stock has a 50 day moving average price of $8.51 and a two-hundred day moving average price of $10.02. Surrozen, Inc. has a 12-month low of $4.50 and a 12-month high of $16.19.
Surrozen Company Profile
Surrozen, Inc, a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. The company is developing antibody-based therapeutics which targets various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system.
See Also
- Five stocks we like better than Surrozen
- Stock Dividend Cuts Happen Are You Ready?
- Can Costco Stock Hit New Highs as Interest Rates Drop?
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- How to Invest in Biotech Stocks
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
Want to see what other hedge funds are holding SRZN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Surrozen, Inc. (NASDAQ:SRZN – Free Report).
Receive News & Ratings for Surrozen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surrozen and related companies with MarketBeat.com's FREE daily email newsletter.